Elekta unveils panoply of products

Radiation therapy device and software developer Elekta unwrapped a variety of product innovations to improve the planning, workflow management and delivery of radiation therapy at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston this week.

The firm is showcasing the U.S. availability of its Elekta Infinity digital linear accelerator. It said the Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision.

Also taking the stage at ASTRO, Elekta will demonstrate its MOSAIQ 2.0, a comprehensive oncology charting solution that tracks patients from registration through long-term follow-up.

The company is displaying its Monaco VMAT Planning, a next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system featuring biological modeling, constrained optimization, and Monte Carlo dose calculation algorithms, representing a fundamentally new approach to IMRT.

Elekta is highlighting the capabilities of its Atlas-Based Autosegmentation (ABAS), a software application that produces an estimate of the anatomy boundary contours needed to create a radiation treatment plan. The standalone, vendor-neutral product significantly reduces the amount of time spent creating and editing patient contours, according to the firm.

The firm is also introducing its Extend Program, a complete system for extending the utilization of Leksell Gamma Knife Perfexion; enabling clinicians to treat indications previously untreatable with Gamma Knife surgery, Elekta said. The rigid carbon-fiber construction of the Extend frame provides maximum stability, enabling the most accurate, non-invasive localization available, the company said.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.